Friday, May 19, 2023
Description
To register visit: https://cvent.me/xwnK9r
The Ohio State University Wexner Medical Center Department of Neurology is proud to offer its first Advanced Practice Provider Neurology Symposium, with both in-person and virtual attendance option.
Neurological complications associated with vaccine administration are uncommon (Miravelle and Schriiner, 2014). The COVID-19 pandemic has created challenges for patients with neurological conditions and those charged with providing related care. Contracting the virus may lead to a worsening of co-morbid neurological conditions (March et al, 2021)? Novel SARS-CoV-2 vaccinations can reduce the occurrence of infection, however health care professionals and clients have questions and concerns regarding the safety of such vaccines. Immunocompromised patients and those receiving immunotherapies are often concerned with the efficacy and cost to benefit ratio of COVID-19 vaccinations. Improving APP awareness of literature and evidence based practice can have a dramatic improvement on patient outcomes. Experts in the field recommend encouraging patients with neurological conditions to be vaccinated, however consideration should be given as to when the vaccine should be given in certain populations. This portion of the presentation will highlight related
research and provide a discussion on the benefit of vaccines in targeted population.
Dates and Times
Start: 5/19/2023 12:00 AM
End: 5/19/2023 7:00 PM
Objectives
- Illustrate the value and incorporation of COVID-10 vaccination in patients with neurological disease
- Integrate all techniques to address vaccine hesitancy and promote adherence to Covid-19 vaccination in patients with Neurological disease
- Describe what constitutes the diagnostic criteria for PD + ET: A basic overview
- Explain what types of pharmacologic treatments are there for PD & ET
- Review FDA approved symptom management options for Alzheimer’s disease
- Review first ever FDA approved disease modifying treatment option for Alzheimer’s disease
- Describe the past and present use of dual antiplatelet therapy (DAPT) in stroke patients
- Review recent trials of DAPT in the treatment of stroke patients
- Identify current diagnostic criteria for episodic and chronic migraine
- Describe pharmacologic options for acute and preventive migraine treatment
- Identify the mechanism of action for newer migraine-specific CGRP antagonist medications
- Illustrate the clinical indication for commonly used anti-seizure medications(ASM)
- Explain common side effects and drug to drug interactions associated with ASMs
- Review ASM in the treatment of co-morbid medical condition
Location
Fawcett Center
400 Olentangy Rive Road
Columbus, OH 43214
Accreditation
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.